Tomáš Janota

995 total citations
34 papers, 303 citations indexed

About

Tomáš Janota is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Tomáš Janota has authored 34 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 9 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Tomáš Janota's work include Cardiac electrophysiology and arrhythmias (8 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Cardiac Arrest and Resuscitation (5 papers). Tomáš Janota is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Cardiac Arrest and Resuscitation (5 papers). Tomáš Janota collaborates with scholars based in Czechia, United Kingdom and Netherlands. Tomáš Janota's co-authors include J Hradec, J Král, Marek Malík, J Marek, A. John Camm, Václav Hána, Michal Kršek, Marek Malik, Katerina Hnatkova and Jan Poloniecki and has published in prestigious journals such as Scientific Reports, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Tomáš Janota

29 papers receiving 285 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomáš Janota Czechia 10 166 112 82 30 24 34 303
Tushar Acharya United States 11 212 1.3× 51 0.5× 72 0.9× 37 1.2× 36 1.5× 30 332
Mehmet Akif Düzenli Türkiye 13 341 2.1× 50 0.4× 65 0.8× 25 0.8× 43 1.8× 36 408
Frank Steensgaard-Hansen Denmark 7 274 1.7× 35 0.3× 37 0.5× 23 0.8× 27 1.1× 15 323
Kwok S. Chong United Kingdom 7 210 1.3× 63 0.6× 214 2.6× 42 1.4× 40 1.7× 9 454
Ryuichi Ushijima Japan 9 199 1.2× 55 0.5× 68 0.8× 26 0.9× 75 3.1× 68 299
Akihiro Sunaga Japan 10 376 2.3× 51 0.5× 59 0.7× 20 0.7× 42 1.8× 45 445
Johanna E. Emmens Netherlands 9 147 0.9× 48 0.4× 47 0.6× 20 0.7× 40 1.7× 16 245
Julian Westphal Germany 9 248 1.5× 100 0.9× 60 0.7× 14 0.5× 78 3.3× 26 344
Bolrathanak Oeun Japan 7 194 1.2× 49 0.4× 31 0.4× 15 0.5× 20 0.8× 17 231
Yuri A. Deychak United States 5 349 2.1× 75 0.7× 162 2.0× 14 0.5× 13 0.5× 8 432

Countries citing papers authored by Tomáš Janota

Since Specialization
Citations

This map shows the geographic impact of Tomáš Janota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Janota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Janota more than expected).

Fields of papers citing papers by Tomáš Janota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Janota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Janota. The network helps show where Tomáš Janota may publish in the future.

Co-authorship network of co-authors of Tomáš Janota

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Janota. A scholar is included among the top collaborators of Tomáš Janota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Janota. Tomáš Janota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rienstra, Michiel, Aaf F.M. Kuijper, Sabine Eijsbouts, et al.. (2025). Flecainide acetate inhalation solution for cardioversion of recent-onset, symptomatic atrial fibrillation: results of the phase 3 RESTORE-1 trial. EP Europace. 27(4). 1 indexed citations
2.
Malík, Jan, Anna Valeriánová, Tomáš Janota, et al.. (2025). Lower cholesterol level on admission predicts poor outcome after prolonged cardiac arrest. Scientific Reports. 15(1). 20512–20512.
3.
Valeriánová, Anna & Tomáš Janota. (2024). Echocardiographic examination of pericardial effusion and cardiac tamponade. 23(1). 24–26.
4.
Rokyta, Richard, et al.. (2019). Fourth universal definition of myocardial infarction. Summary of the document prepared by the Czech Society of Cardiology. Cor et Vasa. 61(2). e106–e122. 1 indexed citations
5.
6.
Kudlička, Jaroslav, Mikuláš Mlček, Jan Bělohlávek, et al.. (2015). Inducibility of ventricular fibrillation during mild therapeutic hypothermia: electrophysiological study in a swine model. Journal of Translational Medicine. 13(1). 72–72. 8 indexed citations
7.
Janota, Tomáš. (2014). Biochemical markers in the diagnosis of myocardial infarction. Cor et Vasa. 56(4). e304–e310. 8 indexed citations
8.
Malík, Jan, et al.. (2012). Arteriovenous Fistula after Femoral Artery Puncture Leading to Pulmonary Edema: The Role of Ultrasonography. Prague Medical Report. 113(1). 49–52. 3 indexed citations
9.
Piťha, Jan, et al.. (2012). Léčba statiny u pacientů s akutním koronárním syndromem. 11(2). 89–90. 3 indexed citations
10.
Janota, Tomáš, et al.. (2010). Effect of Short-Term Maximal Exercise on BNP Plasma Levels inHealthy Individuals. Physiological Research. 59(4). 625–628. 14 indexed citations
11.
Janota, Tomáš, et al.. (2009). Natriuretic peptides – physiology, pathophysiology and clinical use in heart failure. Physiological Research. 58(2). 171–177. 28 indexed citations
12.
Tuka, Vladimír, et al.. (2009). Surprisingly delayed escalation of severe verapamil poisoning. European Journal of Emergency Medicine. 16(2). 100–102. 4 indexed citations
13.
Janota, Tomáš, J Widimský, Tomáš Zelinka, et al.. (2006). Impact of essential hypertension and primary aldosteronism on plasma brain natriuretic peptide concentration. Blood Pressure. 15(5). 302–307. 14 indexed citations
14.
Waktare, Johan, Katerina Hnatkova, Carl Meurling, et al.. (2002). Optimal lead configuration in the detection and subtraction of QRS and T wave templates in atrial fibrillation. Lund University Publications (Lund University). 629–632. 9 indexed citations
15.
Hradec, J, J Král, Tomáš Janota, et al.. (1999). Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog). The American Journal of Cardiology. 83(10). 1506–1509. 57 indexed citations
16.
Janota, Tomáš, et al.. (1997). Autonomic modulation of ventricular rate in atrial fibrillation. American Journal of Physiology-Heart and Circulatory Physiology. 272(4). H1643–H1649. 22 indexed citations
17.
Malík, Marek, et al.. (1996). Changes of QT Intervals Associated with Postural Change in Patients with Chronic Atrial Fibrillation. Pacing and Clinical Electrophysiology. 19(4). 490–495. 4 indexed citations
18.
Kautzner, Josef, Yi Gang, Xavier Copie, et al.. (1996). Interobserver Reproducibility of QT Interval Measurement and QT Dispersion in Patients After Acute Myocardial Infarction. Annals of Noninvasive Electrocardiology. 1(4). 363–374. 28 indexed citations
19.
Hradec, J, J Marek, J Král, et al.. (1993). Long-term echocardiographic follow-up of acromegalic heart disease. The American Journal of Cardiology. 72(2). 205–210. 35 indexed citations
20.
Janota, Tomáš, J Hradec, & J Král. (1992). Heart in adrenal diseases.. PubMed. 34(2). 115–22. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tushar Acharya Breakdown of academic impact, for papers by Mehmet Akif Düzenli Breakdown of academic impact, for papers by Frank Steensgaard-Hansen Breakdown of academic impact, for papers by Kwok S. Chong Breakdown of academic impact, for papers by Ryuichi Ushijima Breakdown of academic impact, for papers by Akihiro Sunaga Breakdown of academic impact, for papers by Johanna E. Emmens Breakdown of academic impact, for papers by Julian Westphal Breakdown of academic impact, for papers by Bolrathanak Oeun Breakdown of academic impact, for papers by Yuri A. Deychak
Rankless by CCL
2026